Literature DB >> 2912430

Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults.

H C Stary1.   

Abstract

In an autopsy study of the evolution of atherosclerotic lesions in young people, we obtained the coronary arteries and aortas of 1160 male and female subjects who died between full-term birth and age 29 years. In this article, we report the light and electron microscopic observations of the coronary arteries of 565 of these subjects in which we fixed the coronary arteries by perfusion with glutaraldehyde under pressure. From birth, the intima was always thicker in the half of the coronary artery circumference opposite the flow-divider wall of a bifurcation (eccentric thickening). In cases where we found lipid in the intima, there was always more in eccentric thickening. Isolated macrophage foam cells in the intima of infants were the earliest sign of lipid retention. These cells occurred in 45% of infants in the first 8 months of life but decreased subsequently. At puberty, more substantial accumulations of macrophage foam cells reappeared in more children. Foam cells were now accompanied by lipid droplets in existing smooth muscle cells and by thinly scattered extracellular lipid. Sixty-five percent of children between ages 12 and 14 years had such lesions. An additional 8% of children had progressed beyond this early stage and had developed advanced preatheroma or atheroma stages. Such advanced lesions, located only in areas of eccentric thickening, were characterized by the addition of massive extracellular lipid that displaced normal cells and matrix and, thus, damaged and weakened the arterial wall.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2912430

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  88 in total

1.  Cell volume and rate of proliferation, but not protein expression pattern, distinguish pup/intimal smooth muscle cells from subcultured adult smooth muscle cells.

Authors:  E McKilligin; D J Grainger
Journal:  Cell Prolif       Date:  2001-10       Impact factor: 6.831

Review 2.  Role of lipid-lowering pharmacotherapy in children.

Authors:  S Tonstad
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

3.  Histological changes and risk factor associations in type 2 atherosclerotic lesions (fatty streaks) in young adults.

Authors:  Satoki Homma; Dana A Troxclair; Arthur W Zieske; Gray T Malcom; Jack P Strong
Journal:  Atherosclerosis       Date:  2011-07-21       Impact factor: 5.162

4.  Age and sex relationship with flow-mediated dilation in healthy children and adolescents.

Authors:  Nicola D Hopkins; Donald R Dengel; Gareth Stratton; Aaron S Kelly; Julia Steinberger; Hanan Zavala; Kara Marlatt; Daniel Perry; Louise H Naylor; Daniel J Green
Journal:  J Appl Physiol (1985)       Date:  2015-08-06

5.  CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1.

Authors:  R Michael Gower; Huaizhu Wu; Greg A Foster; Sridevi Devaraj; Ishwarlal Jialal; Christie M Ballantyne; Anne A Knowlton; Scott I Simon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-28       Impact factor: 8.311

6.  Construction of realistic branched, three-dimensional arteries suitable for computational modelling of flow.

Authors:  S Corney; P R Johnston; D Kilpatrick
Journal:  Med Biol Eng Comput       Date:  2004-09       Impact factor: 2.602

7.  Influence of maternal smoking on neonatal aortic intima-media thickness, serum IGF-I and IGFBP-3 levels.

Authors:  Tamer Gunes; Esad Koklu; Ali Yikilmaz; Mehmet Adnan Ozturk; Mustafa Akcakus; Selim Kurtoglu; Abdulhakim Coskun; Selmin Koklu
Journal:  Eur J Pediatr       Date:  2007-01-04       Impact factor: 3.183

8.  Markers of cholesterol synthesis are elevated in adolescents and young adults with type 2 diabetes.

Authors:  Ivana Semova; Amy E Levenson; Joanna Krawczyk; Kevin Bullock; Kathryn A Williams; R Paul Wadwa; Philip R Khoury; Thomas R Kimball; Elaine M Urbina; Sarah D de Ferranti; David M Maahs; Lawrence M Dolan; Amy S Shah; Clary B Clish; Sudha B Biddinger
Journal:  Pediatr Diabetes       Date:  2020-09-15       Impact factor: 4.866

9.  A robust rabbit model of human atherosclerosis and atherothrombosis.

Authors:  Alkystis Phinikaridou; Kevin J Hallock; Ye Qiao; James A Hamilton
Journal:  J Lipid Res       Date:  2009-01-12       Impact factor: 5.922

10.  Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits.

Authors:  J H Braesen; U Beisiegel; A Niendorf
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.